Clinical Trial Update: Elderly NSCLC/D vs DP (JCOG0207) [Phase 3]

View source ↗

Summary

A Phase 3 trial in elderly non-small cell lung cancer comparing regimens D and DP has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Non-small-cell Lung Cancer | Phase 3 | Status: TERMINATED